EDIT – editas medicine, inc. (US:NASDAQ)
Stock Stats
News
Editas Medicine, Inc. (NASDAQ: EDIT) had its price target lowered by analysts at Evercore ISI from $7.00 to $5.00. They now have an "outperform" rating on the stock.
Editas Medicine, Inc. (NASDAQ: EDIT) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating.
Editas Medicine, Inc. (NASDAQ: EDIT) had its price target lowered by analysts at Royal Bank of Canada from $5.00 to $4.00. They now have a "sector perform" rating on the stock.
Editas Medicine, Inc. (NASDAQ: EDIT) had its price target lowered by analysts at Barclays PLC from $5.00 to $3.00. They now have an "equal weight" rating on the stock.
Editas Medicine, Inc. (NASDAQ: EDIT) had its "neutral" rating re-affirmed by analysts at Chardan Capital.
Form 8-K Editas Medicine, Inc. For: Dec 16
Form 8-K Editas Medicine, Inc. For: Dec 11
Form 8-K Editas Medicine, Inc. For: Dec 06
Form 4 Editas Medicine, Inc. For: Dec 03 Filed by: O'Neill Gilmore Neil
Form 4 Editas Medicine, Inc. For: Dec 03 Filed by: Mei Baisong
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.